INJECTION SITE MUSCLE WEAKNESS

INJECTION SITE MUSCLE WEAKNESS was reported 48 times

INJECTION SITE MUSCLE WEAKNESS is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Acetylcholine Release Inhibitor [EPC] 15 0.0002
1 Thymic Stromal Lymphopoietin Blocker [EPC] 1 0.0001
2 Calcitonin Gene-related Peptide Receptor Antagonist [EPC] 1 0.0001
3 Arteriolar Vasodilator [EPC] 4 0.0001
4 5-alpha Reductase Inhibitor [EPC] 4 0.0000
5 Histamine-1 Receptor Antagonist [EPC] 3 0.0000
6 Dipeptidyl Peptidase 4 Inhibitor [EPC] 1 0.0000
7 alpha-Adrenergic Blocker [EPC] 4 0.0000
8 Aldosterone Antagonist [EPC] 4 0.0000
9 Angiotensin Converting Enzyme Inhibitor [EPC] 3 0.0000
10 beta3-Adrenergic Agonist [EPC] 1 0.0000
11 Central alpha-2 Adrenergic Agonist [EPC] 1 0.0000
12 Calcium [EPC] 2 0.0000
13 beta-Adrenergic Blocker [EPC] 4 0.0000
14 Vitamin B12 [EPC] 4 0.0000
15 Dihydropyridine Calcium Channel Blocker [EPC] 4 0.0000
16 Interleukin-4 Receptor alpha Antagonist [EPC] 6 0.0000
17 Anti-IgE [EPC] 1 0.0000
18 Serotonin Reuptake Inhibitor [EPC] 1 0.0000
19 Atypical Antipsychotic [EPC] 5 0.0000
20 Opioid Agonist [EPC] 3 0.0000
21 HMG-CoA Reductase Inhibitor [EPC] 4 0.0000
22 Vitamin D [EPC] 3 0.0000
23 CD20-directed Cytolytic Antibody [EPC] 3 0.0000
24 Mood Stabilizer [EPC] 2 0.0000
25 P2Y12 Platelet Inhibitor [EPC] 1 0.0000
26 Vitamin C [EPC] 3 0.0000
27 Selective T Cell Costimulation Modulator [EPC] 1 0.0000
28 Folate Analog Metabolic Inhibitor [EPC] 3 0.0000
29 Interferon beta [EPC] 1 0.0000
30 Proton Pump Inhibitor [EPC] 3 0.0000
31 Anti-epileptic Agent [EPC] 1 0.0000
32 Nonsteroidal Anti-inflammatory Drug [EPC] 5 0.0000
33 Angiotensin 2 Receptor Blocker [EPC] 1 0.0000
34 Insulin Analog [EPC] 1 0.0000
35 Tumor Necrosis Factor Blocker [EPC] 2 0.0000
36 Platelet Aggregation Inhibitor [EPC] 1 0.0000
37 Corticosteroid [EPC] 1 0.0000